The World Health Organization (WHO) has approved an Ebola test reagent developed by a Shanghai firm, the company said in a statement on Wednesday.
The real-time diagnostic kit, manufactured by Shanghai ZJ Bio-Tech Co., Ltd. has been listed as eligible for WHO procurement and recommended to be used to diagnose Ebola virus disease worldwide, said the statement.
It said three kits were approved by the WHO so far. The other two are manufactured by developers in the U.S. and Germany.
Last November, the China Food and Drug Administration has approved the test reagent.
Shanghai ZJ Bio-Tech Co., Ltd. is a high-tech enterprise which focuses on developing, manufacturing and selling gene diagnostic reagents. Their products have been sold in more than 70 countries and regions worldwide.
